BITES and CARS and checkpoints, oh my! Updates regarding immunotherapy for myeloid malignancies from the 2018 annual ASH meeting-Reference-Cited by-同舟云学术

BITES and CARS and checkpoints, oh my! Updates regarding immunotherapy for myeloid malignancies from the 2018 annual ASH meeting

Published:2020-09 Issue: Volume:43 Page:100654
ISSN:0268-960X
Container-title:Blood Reviews
language:en
Short-container-title:Blood Reviews

Author:

Przespolewski Amanda C.,Griffiths Elizabeth A.

Funder

Roswell Park Comprehensive Cancer Center

National Cancer Institute

Publisher

Elsevier BV

Subject

Oncology,Hematology

Reference35 articles.

1. Frequency of prolonged remission duration after high-dose cytarabine intensification in acute myeloid leukemia varies by cytogenetic subtype;Bloomfield;Cancer Res,1998

2. Treating acute myeloid leukemia in older adults;Wang;Hematol. Am. Soc Hematol Educ. Program,2014

3. Is the overall survival for older adults with AML finally improving?;Lancet;Best Pract Res Clin Haematol,2018

4. New drugs for acute myeloid leukemia inspired by genomics and when to use them. Hematology, am Soc of Hematol Educ;Pollyea;Program,2018

Cited by 12 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Chimeric Antigen Receptor Therapy in Acute Myeloid Leukemia;Manual of Hematopoietic Cell Transplantation and Cellular Therapies;2024

2. T cells with split CARs specific for NKG2D ligands and PD-L1 exhibit improved selectivity towards monocyte-derived cells while effective in eliminating acute myeloid leukaemia in vivo;Journal of Cancer Research and Clinical Oncology;2023-06-03

3. In the Pipeline: Emerging Therapy for Acute Myeloid Leukaemia;Pathogenesis and Treatment of Leukemia;2023

4. Immune Checkpoint Inhibitors in Acute Myeloid Leukemia: A Meta-Analysis;Frontiers in Oncology;2022-04-21

5. Neue Therapien in der Onkologie – Wirkweise und Nebenwirkungen;Onkologie up2date;2021-12